Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12. Int J Cancer. 2003 Jun 20; 105(3):384-9.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Angiogenesis Inhibitors
Animals
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Breast
Carcinoma
Female
Immunohistochemistry
Interferon-gamma
Interleukin-12
Mammary Neoplasms, Animal
Mice
Mice, Transgenic
Receptor, erbB-2
Tamoxifen
Time Factors